Worldwide Orthobiologics Industry to 2029 - by Product Type, Application and Geography - ResearchAndMarkets.com

The "Orthobiologics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029" report has been added to ResearchAndMarkets.com's offering.

The global orthobiologics market to reach US$ 9.6 billion in 2029 and projected to exhibit a compound annual growth rate (CAGR) of 5.7% during the forecast period from 2021 to 2029.

Orthobiologics are cellular therapy and biologics used to treat or manage certain orthopedic disorders. They include bone void fillers, recombinant growth factors, platelet rich plasma (PRP), autologus conditioned serum, stem cells and grafts. Orthopedic disorders are often treated or managed with medicines and physiotherapy, but may not be effective and surgeries may not be indicated. In such cases orthobiologics are recommended to the patients. Orthobiologics has witnessed increased innovation in the last twenty years. They are administered through injections or surgery.

Intensive research has proved the effectiveness of orthobiologics in healing musculoskeletal injuries, ligament repair, bone regeneration and other orthopedic ailments. PRP for instance has been effective in treating sports injuries and tendonopathies in adults. Over 2 million people in the U.S. alone suffer from cartilage issues. According to Centers for Disease Control and Prevention (CDC), more than 3.5 million children below age 14 receive medical treatment for sports injuries each year in the U.S. Similarly sports injuries are increasing and available targeted solutions are driving the demand for orthobiologics market.

The onset of Covid-19 has impacted the healthcare market significantly. Most of the elective surgeries have taken a back seat due to prioritization of emergency surgeries. To the already burdened healthcare infra and resources, the pandemic has just added to it. Orthopedics surgery had the largest impact with postponement of the surgeries. Many hospitals turned down the ortho surgeries for more emergency surgeries. This reduced the surgeries conducted for both orthopedic surgery and the biologics. The report analyses the impact of covid 19 on the market revenues, micro and macro factor of the orthobiologics market. As orthobiologics is still emerging the price remains higher in comparison to conventional invasive therapies. Additionally, many countries do not cover or provide limited insurance for the same. This is hindering the market growth especially in developing economies.

North America to Remain As the Global Revenue Leader

North America contributed to the largest share in global orthobiologics market in 2019. The largest share for NA is attributed to multiple factors such as well established healthcare infrastructure, accessibility to novel technologies, increase in R&D, increasing awareness among patients withrespect to biologics and demand for minimally invasive surgeries. NA is also witnessing high prevalence rates for obesity and orthopedic degenerative ailments which is further leading to the need of increased orthopedics care. Asia Pacific region is projected to have highest CAGR during the forecast period of 2021 to 2029.

Companies Mentioned

• DePuy Synthes
• Stryker Corporation
• Medtronic plc
• NuVasive Inc.
• Zimmer Biomet
• Globus Medical Inc.
• Orthofix Internamtional NV
• Harvest Technologies Corporation
• Seaspine Holdings Corporation
• RTI Surgicals

Key questions answered in this report

• What are the key market segments in current scenario and in the future by product categories
• What are the key market segments in current scenario and in the future by regions
• What is the key impact of Covid 19 over market revenues and market determinants in the medical aesthetics market?
• What are the primary and secondary macro and micro factors influencing the market growth currently and during the forecast period?
• What are the primary and secondary macro and micro factors deterring the market growth currently and during the forecast period?
• How to overcome the current market challenges and leverage the opportunities in each of the market segment?
• Who are the key players in the medical aesthetics market and what are their key product categories and strategies?
• What are the key strategies - mergers/acquisitions/R&D/strategic partnerships etc that companies are deploying to enhance market revenues and growth?

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Orthobiologics: Market Dynamics and Outlook

3.1. Market Overview

3.2. Drivers

3.3. Challenges

3.4. Opportunities

3.5. Attractive Investment Proposition, by Geography, 2019

3.6. Competitive Analysis: Global Orthobiologics Market, by Key Players, 2019

Chapter 4. Global Orthobiologics Market, by Product Type, 2019-2029 (US$ Mn)

4.1. Overview

4.2. Viscosupplementation Products

4.3. Demineralized Bone Matrices

4.4. Synthetic Orthobiologics

4.5. Bone Morphogenic Protein

4.6. Allografts

4.7. Plasma-Rich Protein

4.8. Bone Marrow Aspirate Concentrate

Chapter 5. Global Orthobiologics Market, by Application, 2019-2029 (US$ Mn)

5.1. Overview

5.2. Osteoarthritis and Degenerative Arthritis

5.3. Spinal Fusion

5.4. Soft-Tissue Injuries

5.5. Fracture Recovery

5.6. Maxillofacial and Dental Applications

Chapter 6. Global Orthobiologics Market, by Geography, 2019-2029 (US$ Mn)

6.1. North America Orthobiologics Market Analysis, 2019-2029

6.2. Europe Orthobiologics Market Analysis, 2019-2029

6.3. Asia Pacific Orthobiologics Market Analysis, 2019-2029

6.4. Latin America Orthobiologics Market Analysis, 2019-2029

6.5. Middle East & Africa Orthobiologics Market, 2019-2029

Chapter 7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/6bsmjb

View source version on businesswire.com: https://www.businesswire.com/news/home/20210304005529/en/